AKT1 and cancer: Additionally, to assess the potential role of PD-L2 in regulating protumoral pathways involved in cancer cell aggressiveness, the modulation of ERK and Akt/PKB pathways were evaluated through Western blot analysis in PD-L2+ and PD-L2– cells.